filings.toolsItem 1A. Risk Factors
2K characters. Original on sec.gov · Markdown
Item 1A. Risk Factors
There have been no material changes to the risk factors disclosed in Item 1A in our 2023 10-K.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Common stock repurchases during the three months ended March 31, 2024:
| Period | Total Number of Shares Purchased | Average Price Paid Per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs | |||||||||||||||||||
| January 1 - January 31, 2024 | — | — | — | ||||||||||||||||||||
| February 1 - February 29, 2024 | — | — | — | ||||||||||||||||||||
| March 1 - March 31, 2024 | 1,923,718 | $ | 93.64 | — | — | ||||||||||||||||||
| 1,923,718 | $ | 93.64 | — | — |
During the three months ended March 31, 2024, we purchased 1,923,032 shares of our common stock in the open market for general corporate purposes, and we withheld 686 shares from employees to satisfy estimated statutory income tax obligations related to vesting of restricted stock awards. The value of the common stock withheld was based on the closing price of our common stock on the applicable vesting date. There were no unregistered sales of equity securities during the three months ended March 31, 2024.
Previous: Item 4. CONTROLS AND PROCEDURES · Next: Item 5. Other Information